Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125499 · ClinicalTrials.gov registry record
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
A clinical trial of Mild to Moderate Knee OA, sponsored by OrthoTrophix.
- Completed
- Registry status
- 54
- Enrollment target
- 1
- Study location
NCT03125499: Completed study of Mild to Moderate Knee OA, sponsored by OrthoTrophix.
NCT03125499 is a study of Mild to Moderate Knee OA that has completed, run by OrthoTrophix. The registered enrollment target is 54 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03125499, a study of Mild to Moderate Knee OA, has completed, sponsored by OrthoTrophix.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the long-term changes in patellar cartilage thickness in TPX-100 versus placebo-treated knees in subjects who participated in Study TPX-100-1 or TPX-100-2.
Primary Outcome
Quantitative analysis of long-term changes in patellar cartilage thickness by MRI
Conditions Studied
Interventions
- OTHER Previous treated with TPX-100
Study Locations (1)
California
- Dr. Samy Metyas - Covina
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-07-27 |
| Est. Completion | 2018-03-01 |
What the finished NCT03125499 record still lists
NCT03125499 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 1 condition, with Mild to Moderate Knee OA appearing as the primary indexed condition, and to 1 intervention - of which Previous treated with TPX-100 is the first listed.
NCT03125499 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03125499 about?
NCT03125499 is a clinical study titled "A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees". To evaluate the long-term changes in patellar cartilage thickness in TPX-100 versus placebo-treated knees in subjects who participated in Study TPX-100-1 or TPX-100-2.
What is the current status of trial NCT03125499?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-07-27. Estimated completion is 2018-03-01.
What conditions does trial NCT03125499 study?
This clinical trial studies the following conditions: Mild to Moderate Knee OA.
What interventions are being tested in trial NCT03125499?
The interventions under investigation include: Previous treated with TPX-100 (OTHER).
Who is sponsoring clinical trial NCT03125499?
This trial is sponsored by OrthoTrophix, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03125499 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI